These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32153391)

  • 1. Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia.
    Hulshof TA; Zuidema SU; Janus SIM; Luijendijk HJ
    Front Pharmacol; 2019; 10():1701. PubMed ID: 32153391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
    Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.
    Yunusa I; Alsumali A; Garba AE; Regestein QR; Eguale T
    JAMA Netw Open; 2019 Mar; 2(3):e190828. PubMed ID: 30901041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta-epidemiological study of randomized trials.
    Hulshof TA; Zuidema SU; van Meer PJK; Gispen-de Wied CC; Luijendijk HJ
    Int J Methods Psychiatr Res; 2019 Mar; 28(1):e1757. PubMed ID: 30515916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amisulpride for schizophrenia.
    Mota NE; Lima MS; Soares BG
    Cochrane Database Syst Rev; 2002; 2002(2):CD001357. PubMed ID: 12076408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Run-in periods and clinical outcomes of antipsychotics in dementia: A meta-epidemiological study of placebo-controlled trials.
    Hulshof TA; Zuidema SU; Gispen-de Wied CC; Luijendijk HJ
    Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):125-133. PubMed ID: 31730266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics for treatment of delirium in hospitalised non-ICU patients.
    Burry L; Mehta S; Perreault MM; Luxenberg JS; Siddiqi N; Hutton B; Fergusson DA; Bell C; Rose L
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD005594. PubMed ID: 29920656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.
    Schneider LS; Dagerman K; Insel PS
    Am J Geriatr Psychiatry; 2006 Mar; 14(3):191-210. PubMed ID: 16505124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis.
    Tan L; Tan L; Wang HF; Wang J; Tan CC; Tan MS; Meng XF; Wang C; Yu JT
    Alzheimers Res Ther; 2015; 7(1):20. PubMed ID: 25897331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotics for fibromyalgia in adults.
    Walitt B; Klose P; Üçeyler N; Phillips T; Häuser W
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011804. PubMed ID: 27251337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia.
    Van Leeuwen E; Petrovic M; van Driel ML; De Sutter AI; Vander Stichele R; Declercq T; Christiaens T
    Cochrane Database Syst Rev; 2018 Apr; 3(3):CD007726. PubMed ID: 29605970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.